KFDA Focuses on Biotechnology Based Biopharmaceuticals

Published: 2004-12-31 06:56:00

Updated: 2004-12-31 06:56:00

The Korea Food and Drug Administration (KFDA) recently released the next year's plans on improving the administrative efforts dealing with biotechnology-based biopharmaceutical products, to further strengthen overall safety and quality measures.

Key Biopharmaceutical Initiatives:

(a) Improved Safety Measures on Biopharmaceutical Products
The KFDA will strengthen its inspection activitie...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.